SB-0110

N/A

Report date: 2026/03/10 20:00:16
NMEFirst In Class

Base Information

Drug NameSB-0110
Drug Alias NameSB-0110SB0110
ClassificationSmall molecules
Mechanisms of ActioncAMP-dependent protein kinase type II-beta regulatory subunit allosteric modulators
TargetscAMP-dependent protein kinase type II-beta regulatory subunit
Therapy Area/IndicationsLevodopa-induced dyskinesiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSinopia Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSinopia Biosciences IncNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsLevodopa-induced dyskinesiaParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A